Pj. Kruzich et Re. See, An evaluation of the role of 5-MT2 receptor antagonism during subchronic antipsychotic drug administration in rats, BRAIN RES, 875(1-2), 2000, pp. 35-43
A widely postulated mechanism of action for the atypical profile of many no
vel antipsychotic drugs (APDs) is their relatively high affinity for 5-HT2
receptors. The present study investigated motor function and striatal dopam
ine (DA) efflux and metabolism in rats given 21 daily injections of drugs t
hat differed in 5-HT2 affinity. These drugs included: risperidone (high 5-H
T2A/2C/high D-2), clozapine (high 5-HT2A/2C/low D-2), haloperidol (low 5-HT
2A/2C/high D-2), haloperidol+ritanserin (selective 5-HT2A/2C), or vehicle.
Rats injected with haloperidol (0.5 mg/kg) or haloperidol+ritanserin (0.5 m
g/kg and 1.0 mg/kg, respectively) showed extreme catalepsy on day 1, but si
gnificantly decreased catalepsy when tested again on days 7 and 21. Acute o
r subchronic risperidone (0.05 or 0.5 mg/kg), clozapine (20 mg/kg), or vehi
cle did not induce significant catalepsy. Microdialysis performed 24 h afte
r the last injection demonstrated that rats treated with risperidone, cloza
pine, or vehicle showed similar increases in DA efflux and metabolism follo
wing an acute injection of a selective DA D-2/3 antagonist (raclopride, 0.5
mg/kg). DA efflux showed an attenuated response to raclopride in the halop
eridol alone group; this effect was less apparent in the haloperidol+ritans
erin group. However, both of these groups showed a similar tolerance effect
to the raclopride-induced increase in DA metabolites. These results sugges
t that the profile seen after subchronic risperidone more closely resembles
clozapine than haloperidol. While ritanserin reduced the tolerance-like ef
fects of haloperidol on striatal DA efflux, the overall results demonstrate
that potent 5-HT2 blockade alone may not entirely account for the distinct
ive profile of novel APDs. (C) 2000 Elsevier Science B.V. All rights reserv
ed.